Patents by Inventor Xufang Tian

Xufang Tian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160158307
    Abstract: The present invention provides a family of novel cytotoxic pentapeptides, which show potent antitumor activities against several cancer lines. The antibody-drug conjugates prepared from those pentapeptides can efficiently kill cancer cells.
    Type: Application
    Filed: February 15, 2016
    Publication date: June 9, 2016
    Applicant: ACES Pharma Inc.
    Inventors: Shanghui Hu, Lucy Xiumin Zhao, Jinying Ning, Xufang Tian, Chao Li, Wei Hu, Xu Liu, Bonnie Y. Hu
  • Patent number: 9260478
    Abstract: The present invention provides a family of novel cytotoxic pentapeptides, which show potent antitumor activities against several cancer lines. The antibody-drug conjugates prepared from those pentapeptides can efficiently kill cancer cells.
    Type: Grant
    Filed: October 16, 2014
    Date of Patent: February 16, 2016
    Inventors: Shanghui Hu, Lucy Xiumin Zhao, Jinying Ning, Xufang Tian
  • Publication number: 20150284425
    Abstract: The present invention provides a family of novel cytotoxic pentapeptides, which show potent antitumor activities against several cancer lines. The antibody-drug conjugates prepared from those pentapeptides can efficiently kill cancer cells.
    Type: Application
    Filed: October 16, 2014
    Publication date: October 8, 2015
    Applicant: ACES Pharma Inc.
    Inventors: Shanghui Hu, Lucy Xiumin Zhao, Jinying Ning, Xufang Tian